“CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY”, ijms, vol. 5, no. 05, pp. 396–403, Jun. 2025, doi: 10.55640/.